Insider · CIK 0001797819
Marianne De Backer
ceoofficerdirector
Files at VIR (Vir Biotechnology, Inc.). First filing Feb 25, 2025, latest Feb 26, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $909k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VIR: Vir Biotechnology, Inc.
VIROct 9, 2026 · close 11.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | Vir Biotechnology, Inc. | $141k 14,762 shares | -1% | +122% from low0% from high | |
| 24Weak | Vir Biotechnology, Inc. | $142k 19,039 shares | -2% | +74% from low-22% from high | |
| 22Weak | Vir Biotechnology, Inc. | $474k 79,712 shares | -9% | 0% from low-52% from high | |
| 24Weak | Vir Biotechnology, Inc. | $152k 16,122 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -14,762 | $9.53 | $141k | 1,020,704 | Feb 26, 2026 |
| Feb 22, 2026 | VIR Vir Biotechnology, Inc. | AGrant or award Common Stock10b5-1 | +285,000 | $0.00 | $0 | 1,054,505 | Feb 24, 2026 |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -19,039 | $7.45 | $142k | 1,035,466 | Feb 24, 2026 |
| Feb 22, 2026 | VIR Vir Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +570,000 | $0.00 | $0 | 570,000 | Feb 24, 2026 |
| Apr 3, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -79,712 | $5.95 | $474k | 769,505 | Apr 4, 2025 |
| Feb 22, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Common Stock10b5-1 | +240,000 | $0.00 | $0 | 865,339 | Feb 25, 2025 |
| Feb 24, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -16,122 | $9.45 | $152k | 849,217 | Feb 25, 2025 |
| Feb 22, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +480,000 | $0.00 | $0 | 480,000 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.